We recently compiled a list of the 11 Best Stocks To Invest In For Grandchildren. In this article, we are going to take a ...

The upgrade is based on Moody's expectation of robust earnings growth for Eli Lilly in the coming years. This growth is anticipated to be driven by the company's incretin portfolio, which includes ...

Viking Therapeutics got the market's attention with robust phase 2 results for VK2735, a potential weight loss therapy.

Lilly Endowment Inc., a significant shareholder of Eli Lilly & Co. (NYSE:LLY), disclosed the sale of shares worth approximately $183.6 million, according to recent filings. The transactions, which ...

Viking Therapeutics stock jumped higher last year because it looks like a dual GLP-1/GIP agonist it's developing could ...

Compounded semaglutide is legal, but it's not regulated in the same way as medications like Ozempic and Wegovy.

As the first earnings season of 2025 unfolds, investors are likely analyzing financial reports to refine their portfolio ...

Below are some additional issues of concern regarding Elanco and animal health. — In 2020, Elanco Animal Health completed its acquisition of Bayer’s animal health division. Bayer probably needed to ...